F630-0873 Screening compound: 1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)thiophen-2-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline

F630-0873 Screening compound: 1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)thiophen-2-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline
F630-0873 Screening compound: 1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)thiophen-2-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound F630-0873
1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)thiophen-2-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F630-0873

Molecular Formula

C19H19N3O3S2 (C19 H19 N3 O3 S2)

Compound Name

1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)thiophen-2-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline

IUPAC name

1-{[5-(5-cyclobutyl-134-oxadiazol-2-yl)thiophen-2-yl]sulfonyl}-1234-tetrahydroquinoline

SMILES

O=S(c1ccc(-c2nnc(C3CCC3)o2)s1)(N(CCC1)c2c1cccc2)=O

InChI

InChI=1S/C19H19N3O3S2/c23-27(24,22-12-4-8-13-5-1-2-9-15(13)22)17-11-10-16(26-17)19-21-20-18(25-19)14-6-3-7-14/h1-2,5,9-11,14H,3-4,6-8,12H2

InChI Key

BWXKSRZOTJQHSP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27180289

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

401.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.534

Distribution Coefficient, logD

3.534

Water Solubility, LogSw

-3.55

Polar Surface Area

63.176

Acid Dissociation Constant (pKa)

24.75

Base Dissociation Constant (pKb)

-0.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

F630-0873 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

KRAS-Targeted Library (16000 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F630-0873 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F630-0873?
Check Price and Availability of F630-0873, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F630-0873 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F630-0873
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F630-0873
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F630-0873 available by request